Cargando…
How can artificial intelligence optimize value-based contracting?
Efforts in the pharmaceutical market have been aimed at ensuring that the benefits obtained from the introduction of new therapies justify the associated costs. In recent years, drug payment models in healthcare have undergone a dramatic shift from focusing on volume (i.e., size of the target clinic...
Autores principales: | Poveda, Jose Luis, Bretón-Romero, Rosa, Del Rio-Bermudez, Carlos, Taberna, Miren, Medrano, Ignacio H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673444/ https://www.ncbi.nlm.nih.gov/pubmed/36401303 http://dx.doi.org/10.1186/s40545-022-00475-3 |
Ejemplares similares
-
Towards a symbiotic relationship between big data, artificial intelligence, and hospital pharmacy
por: Del Rio-Bermudez, Carlos, et al.
Publicado: (2020) -
Symptoms timeline and outcomes in amyotrophic lateral sclerosis using artificial intelligence
por: Segura, Tomás, et al.
Publicado: (2023) -
Commentary: Artificial intelligence for everything: Can we trust it?
por: Akkara, John Davis, et al.
Publicado: (2020) -
Artificial intelligence, human intelligence, and the future of public health
por: Bhattacharya, Sudip
Publicado: (2022) -
Assessing the Performance of Clinical Natural Language Processing Systems: Development of an Evaluation Methodology
por: Canales, Lea, et al.
Publicado: (2021)